CARLSBAD, Calif., March 11 /PRNewswire/ -- SynergEyes, Inc., the developer of the first FDA-cleared hybrid contact lens specifically designed for patients with keratoconus, has launched a new educational website (http://www.SharingOneVision.com) for patients seeking information on the eye disease keratoconus and treatment with hybrid contact lenses.
Keratoconus is a highly debilitating eye condition in which the cornea thins and becomes cone-shaped and irregular rather than spherical like a normal cornea. SharingOneVision.com provides patients with a website where they can learn about keratoconus, read detailed information on the SynergEyes(R) KC hybrid contact lenses and view stories from other keratoconus patients who have been successfully treated with hybrid contact lenses.
SharingOneVision.com offers a doctor locator search tool to make it easy for patients to find certified practitioners that fit SynergEyes lenses. In addition, keratoconus patients can watch educational videos on how to properly insert, remove and clean hybrid contact lenses.
"SynergEyes is committed to improving the quality of life for the thousands of people worldwide suffering with keratoconus. SharingOneVision.com provides patients with access to the most up-to-date information on hybrid contact lenses at all times," said Kellie Kaseburg, Vice President of Global Marketing for SynergEyes, Inc.
The SynergEyes(R) KC contact lens utilizes revolutionary hybrid technology to offer the crisp, clear vision of a rigid gas permeable (RGP) contact lens with the all-day comfort and convenience of a soft lens. The result is a custom-designed "hybrid" lens that gives keratoconus patients consistent, healthy vision they can count on to live a productive life.
In addition to SynergEyes(R) KC for the treatment of keratoconus, the SynergEyes family of hybrid contact lenses with FDA market clearance includes SynergEyes(R) A for naturally occurring ametropia, targeting patients with astigmatism, current RGP lens wearers and patients demanding optimized vision; SynergEyes(R) Multifocal for presbyopia; and SynergEyes(R) PS for patients with post-surgery or post-trauma refractive errors.
Contact: Kellie Kaseburg Vice President, Marketing email@example.com 877.SEE.2012
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
|SOURCE SynergEyes, Inc.|
Copyright©2009 PR Newswire.
All rights reserved